NCR3 and neoplasm: Production of T cells based on the NKp30 chimeric receptor is considered an effective method to detect and treat B7-H6–positive tumor cells (128), which can increase NK cell-mediated tumor destruction and increase the release of bispecific immune oligomeric proinflammatory cytokines (129).